newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

GENEVA, SWITZERLAND / ACCESSWIRE / September 7, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company seeking to provide patients therapeutic benefit from selected specia